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Background: People of non-White ethnicity have a higher risk of 
severe outcomes following influenza infection. It is unclear whether 
this is driven by an increased risk of infection or complications. We 
therefore aimed to investigate the incidence of clinically diagnosed 
influenza/influenza-like illness (ILI) by ethnicity in England from 2008-
2018. 
Methods: We used linked primary and secondary healthcare data 
(from the Clinical Practice Research Datalink [CPRD] GOLD and Aurum 
databases and Hospital Episodes Statistics Admitted Patient Care [HES 
APC]). We included patients with recorded ethnicity who were aged 
40-64 years and did not have a chronic health condition that would 
render them eligible for influenza vaccination. ILI infection was 
identified from diagnostic codes in CPRD and HES APC. We calculated 
crude annual infection incidence rates by ethnic group. Multivariable 
Poisson regression models with random effects were used to estimate 
any ethnic disparities in infection risk. Our main analysis adjusted for 
age, sex, and influenza year. 
Results: A total of 3,735,308 adults aged 40-64 years were included in 
the study; 87.6% White, 5.2% South Asian, 4.2% Black, 1.9% Other, and 
1.1% Mixed. We identified 102,316 ILI episodes recorded among 
94,623 patients. The rate of ILI was highest in the South Asian (9.6 per 
1,000 person-years), Black (8.4 per 1,000 person-years) and Mixed (6.9 
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per 1,000 person-years) ethnic groups. The ILI rate in the White ethnic 
group was 5.7 per 1,000 person-years. After adjustment for age sex 
and influenza year, higher incidence rate ratios (IRR) for ILI were seen 
for South Asian (1.70, 95% CI 1.66-1.75), Black (1.48, 1.44-1.53) and 
Mixed (1.22, 1.15-1.30) groups compared to White ethnicity. 
Conclusions: Our results suggest that influenza infection risk differs 
between White and non-White groups who are not eligible for routine 
influenza vaccination.
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Introduction
People from ethnic minority backgrounds are represented 
disproportionately among patients with severe coronavirus disease 
2019 (COVID-19). Recent research has found people of Black 
and South Asian ethnicity have increased risk of severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, 
COVID-19-related hospitalization and death, independent of 
deprivation, occupation, household size, and underlying health 
conditions1,2.
The COVID-19 pandemic has reinforced the importance of 
seasonal influenza vaccination. By preventing influenza-related 
hospitalization, vaccination can minimize the risk of hospital-
acquired COVID-19 (co-) infection for these individuals and 
reduce health service pressures, particularly the need for isola-
tion of patients with respiratory symptoms awaiting COVID-19 
test results.
In the United Kingdom (UK), the influenza vaccine is routinely 
recommended for adults aged ≥65 years, or people <65 years 
with underlying health conditions. These recommendations 
formed the basis of the original guidance to identify patients 
at moderate- and high-risk of COVID-19. Influenza vaccine 
recommendations were expanded for the 2020/21 season to 
include all adults ≥50 years3. However, vaccine uptake among 
clinical risk groups is low, particularly for Black and Mixed 
Black ethnic groups4. In addition, people of non-White ethnic-
ity have higher risk of severe outcomes following influenza 
infection5,6. It is unclear whether this is driven by the risk of 
infection or complications, with most research focused on distal 
outcomes rather than initial infection risk.
Here we investigate the incidence of influenza and 
influenza-like illness (ILI) by ethnicity from 2008–2018 among 
people not eligible for routine influenza vaccination, to consider 
disparities in infection risk.
Methods
Study design and data sources
We conducted a retrospective cohort study using anonymized 
primary care data from the UK Clinical Practice Research 
Datalink (CPRD) GOLD and Aurum databases7,8 with linked 
secondary care data from the Hospital Episodes Statistics 
Admitted Patient Care (HES APC) database and death data 
from the Office for National Statistics. The data include 
diagnoses, prescriptions, immunizations and demographics. The 
corresponding author had full access to all CPRD GOLD 
and Aurum data used in the study, with relevant linked patient 
HES APC and ONS death data obtained from CPRD.
Study population
We included all adults aged 40–64 years registered at a 
CPRD contributing practice in England between 01/09/2008 
and 31/08/2018 who were present in the GOLD and Aurum 
datasets. We then excluded among this study population 
any patients with a health condition indicative of influenza 
vaccination eligibility (Table 1), and those who had ever received 
pneumococcal vaccination, or influenza vaccination in the 
12 months before baseline (all codes listed here, DOI: awaiting). 
Among the final study population, we started study follow-up 
to identify diagnoses of ARI (outcome of interest) 
at the latest of 12 months after current registration, up-to-
research-standard (GOLD only), 40th birthday, or 01/09/2008. 
Follow-up ended at the earliest of; a new diagnosis of a con-
dition conferring eligibility for vaccination, pneumococcal or 
influenza vaccination, death, transfer out, the practice’s last 
data collection, 65th birthday, or 31/08/2018.
Variables
Self-reported ethnicity was captured in CPRD and 
supplemented with HES APC if missing in CPRD. We grouped 
ethnicity into the five and 16 census categories of White 
(British, Irish, Other White), South Asian (Indian, Pakistani, 
Bangladeshi, other Asian), Black (African, Caribbean, other 
Black), Other (Chinese, all other), and Mixed (White and 
Asian, White and African, White and Caribbean, Other Mixed).
Influenza/ILI infection was identified from diagnostic codes 
in CPRD and HES APC. In a second analysis, we expanded 
our outcome definition to acute respiratory infection (ARI), 
additionally including codes for pneumonia, acute bronchitis, 
or other acute infections suggestive of lower respiratory tract 
involvement (all codes listed here, DOI: https://doi.org/10.17037/
DATA.00002102).
Statistical analysis
All analyses were done with Stata (version 16). We calculated 
crude annual infection incidence rates by ethnic group with 
age- and sex-stratification. Multivariable Poisson regression 
models with random effects, to account for multiple infections 
in the same patient, were used to estimate any ethnic dispari-
ties in infection risk. Our main analysis adjusted for age, sex, 
and influenza season/year. A second model additionally adjusted 
for region of residence and socioeconomic status (based on 
patient-level Townsend score quintiles), which may both confound 
and mediate an association between ethnicity and infection.
An earlier version of this article can be found on medRxiv 
(https://doi.org/10.1101/2021.01.15.21249388).
Results
Our cohort included 3,735,308 patients (Figure 1), of 
whom 87.6% were White (n=3,271,115), 5.2% South 
Asian (n=196,262), 4.2% Black (n=157,075), 1.9% Other 
(n=69,440), and 1.1% Mixed (n=41,416) (Table 2). We excluded 
511,682 (12.0%) patients with no recorded ethnicity; this 
group had longer follow-up, fewer consultations and were 
more likely to be male than the included study population 
(Table 2). 16-category ethnicity was known for 3,035,689 of 
the cohort (with HES ethnicity breakdown beyond white and 
mixed not available), of whom 76.3% were White British, 0.9% 
Irish, 7.7% Other White, 2.6% Indian, 1.3% Pakistani, 0.4% 
Bangladeshi, 2.2% Other Asian, 2.8% African, 1.5% Caribbean, 
0.9% Other Black, 0.7% Chinese, and 1.5% Other (Table 3). 
Non-White populations were younger and resided in more 
deprived areas than the White population, while a higher 
proportion of the White population were obese.
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Figure 1. Study population flow chart.
Table 1. Definitions used for developing exclusion conditions using Clinical Practice Research Datalink (CPRD) code lists.
Health condition Study definition
Cardiovascular disease (CVD) Any previous clinical diagnosis, major intervention for, or clinical review specific to CVD including heart 
disease (congenital or otherwise), heart failure, stroke or transient ischaemic attack. 
Chronic liver disease Any previous clinical diagnosis of, or clinical review specific to, chronic liver disease including cirrhosis, 
oesophageal varices, biliary atresia and chronic hepatitis. 
Chronic kidney disease (CKD) Any previous clinical diagnosis of, or clinical review specific to, CKD stages 3-5, history of dialysis or renal 
transplant in Gold or Aurum. Or with estimated glomerular filtration rate (eGFR) to classify CKD stage 
3-5 in Gold. 
Chronic respiratory disease Any previous clinical diagnosis of, or clinical review specific to, chronic respiratory disease, including 
chronic obstructive pulmonary disease, emphysema, bronchitis, cystic fibrosis, or fibrosing interstitial 
lung diseases. 
Asthma Any previous clinical diagnosis of, or clinical review specific to, asthma with at least two prescriptions of 
inhaled steroids in the year before baseline. Or any previous hospitalisation for asthma.
Chronic neurological disease Any previous clinical diagnosis of, or clinical review specific to, a neurological disease such as Parkinson’s 
disease, motor neurone disease, multiple sclerosis (MS), cerebral palsy, dementia or a learning/
intellectual disability.
Diabetes mellitus Any previous diagnosis of, or clinical review specific to, diabetes mellitus, or with a prescription for 
medication used to treat diabetes. 
Asplenia/sickle cell disease Any previous clinical diagnosis of, or clinical review specific to, asplenia or dysfunction of the spleen 
(including sickle cell disease but not sickle cell trait). 
Severe obesity Latest body mass index before baseline was ≥40 kg/m2.
Immunosuppression
Any previous clinical diagnosis of, or clinical review specific to, HIV, solid organ transplant or other 
permanent immunosuppression (such as genetic conditions compromising immune function). 
In the two years before baseline: clinical diagnosis of, or clinical review specific to, aplastic anaemia or 
haematological malignancy, or receiving a bone marrow or stem cell transplant. 
In the year before baseline: previous clinical diagnosis of, or clinical review specific to, other/unspecified 
immune deficiency or receiving chemotherapy or radiotherapy.
In the year before baseline: prescription of biological therapy or at least 2 prescriptions for oral steroids 
or other immunosuppressants including DMARDS, Methotrexate, Azathioprine, or corticosteroid 
injections. 
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Figure 2. Overall, age- and sex-stratified annual incidence rates for influenza / influenza-like illness by ethnic group.
We identified 102,316 influenza/ILI episodes recorded 
among 94,623 patients, and 560,860 ARI episodes among 
421,349 patients. The rate of influenza/ILI was highest in the 
South Asian group (9.6 per 1,000 person-years) followed by the 
Black group (8.4 per 1,000 person-years) (Figure 2, Table 4). 
In all ethnic groups the influenza/ILI rates were higher in women 
than men and decreased with age.
After adjustment for age, sex and year, the incidence rate ratio 
(IRR) for influenza/ILI was higher for South Asian (1.70, 95% 
CI 1.66-1.75), Black (1.48, 95% CI 1.44-1.53), and Mixed 
(1.22, 95% CI 1.15-1.30) groups compared to the White group 
(Figure 3, Table 4). When broken down into the 16 categories, 
the IRR for influenza/ILI was higher in all groups included in 
the South Asian, Black and Mixed broad ethnic classifications, 
with the highest IRR in the Bangladeshi group (2.26, 95% 
CI 2.05-2.49). After additional adjustment for deprivation and 
region, results remained similar.
For ARI, the IRR was higher in the South Asian group 
(1.07, 95% CI 1.05-1.09) when compared to the White group, 
but lower in the Black (0.81, 95% CI 0.80-0.83), Mixed 
(0.84, 95% CI 0.81-0.88) and Other (0.65, 95% CI 0.63-0.67) 
groups. Using the 16 categories, the IRR for ARI was only 
higher for the Pakistani (1.42, 95% CI 1.37-1.46) and 
Bangladeshi (1.41, 95% CI 1.33-1.50) groups when compared 
with the White British group.
Discussion
We showed an increased rate of influenza/ILI among Black, 
South Asian and Mixed groups. Specifically, those of Indian, 
Pakistani, Bangladeshi and African ethnicity had the highest 
rate compared to the White British group. When using our 
broader outcome of ARI, we only found an increased rate in the 
South Asian group with decreased rates in Black, Mixed and 
Other groups.
Our results suggest influenza infection risk differs between 
White and non-White groups. Such findings are consistent with 
studies of other acute viral respiratory infections including 
those which investigated the ethnic disparities in severe influ-
enza outcomes, particularly during the 2009 H1N1 pandemic5,6 as 
well as studies of COVID-19 infection risk and severe outcomes1.
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Figure 3. Ethnic differences in the incidence ratio risks of influenza / influenza-like illness and acute respiratory infections. All 
White is the reference category for comparison of ethnicity in 5 categories. British is the reference category for comparison of ethnicity in 
16 categories. Models were adjusted for 5-year age band, sex, year. 
Our study was conducted among patients not eligible for 
vaccination, and so disparities cannot be explained by differ-
ences in vaccine uptake or effectiveness: there are potentially even 
larger ethnic differences in influenza incidence among 
those eligible for influenza vaccine due to inequalities in chronic 
disease patterns. Since social mixing and household contact 
are important considerations for influenza/ILI transmission our 
findings are relevant to the whole population. People of 
non-white ethnicity tend to live in larger, multi-generational 
households with extended kinship and social networks9,10. 
Therefore, understanding ethnic disparities in respiratory 
infections across both high- and low-risk populations remains 
important for preventing hospitalizations.
Here we have presented results of a large population-based 
cohort study using nationally representative data. Exclud-
ing patients eligible for influenza vaccination due to chronic 
medical conditions should have reduced confounding. 
Nevertheless, our study may be impacted by some limitations. 
Under-diagnosis of health conditions may differ by ethnicity, 
with people from some ethnic groups less likely to be excluded 
from our study population but more likely to have an 
undiagnosed, and therefore unmanaged condition, which 
may affect influenza risk. Ethnicity may be less well recorded 
in GP records for individuals without a chronic condition 
requiring frequent consultation, but financial incentivization 
between 2006–2011 boosted completion in GP records. Using 
hospital data boosted the completeness of ethnicity recording 
in our study population from 74% to 88%. Influenza infection 
in our study was based on clinical diagnosis. Clinically identi-
fied influenza depends not only on healthcare attendance but 
also clinical coding practices, both of which may be associ-
ated with ethnicity. However, our results are consistent with 
other studies which used laboratory-confirmed measures of 
acute viral respiratory infections1,5,6. Our differing results for 
influenza/ILI and ARI outcomes may be attributable to the 
lack of specificity of ARI codes for influenza. We excluded 
individuals with known risk factors for influenza; it may be 
that other conditions are relevant risk factors for ARI generally.
Ethnic inequalities in the incidence of respiratory infections 
could arise because of differences in risk of exposure, driven 
by factors such as occupation and household composition11, as 
well as inequalities in access to care. We excluded children who 
are a key driver for influenza transmission; examining ethnic 
inequalities for infection risk in children is an area for 
future research. Unequal access to treatments will also affect the 
likelihood of adverse outcomes after infection.
The COVID-19 pandemic has highlighted ethnic inequalities 
in infection risk, which our study found are also present for 
influenza. This reinforces the urgency of addressing lower 
influenza vaccine uptake among minority ethnic groups, 
which could be combined with public health interventions to 
promote equal uptake of COVID-19 vaccination12.
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Data availability 
Source data
The patient data used in this study are supplied from Clinical 
Practice Research Datalink (CPRD; www.cprd.com) but 
restrictions apply to the availability of these data, which 
were obtained under licence from the UK Medicines and 
Healthcare products Regulatory Agency, and so are not 
publicly available. For re-using these data, an application 
must be made directly to CPRD. Instructions for how to 
submit an application and the conditions under which access 
will be granted are explained at https://www.cprd.com/ 
research-applications.
Ethical approval
The study was approved by the CPRD Independent Scientific 
Advisory Committee (Protocol number: 19_209A2) and the 
London School of Hygiene and Tropical Medicine Research 
Ethics Committee (Reference: 17894).
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